NeuroOne Medical Technologies Corporation - Common Stock (NMTC)
1.1500
0.00 (0.00%)
Neuroone Medical Technologies Corp is a pioneering medical technology company focused on developing innovative solutions for neurological disorders
The company specializes in creating advanced devices and technologies aimed at improving the diagnosis and treatment of conditions such as epilepsy, Parkinson's disease, and chronic pain. Neuroone's offerings include breakthrough electrode systems that facilitate precise brain interaction, enabling better therapeutic outcomes. Through their commitment to research and development, Neuroone seeks to address critical healthcare needs in the neurology field while enhancing patients' quality of life.
NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQSGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 50 points on Tuesday. The Dow traded up 0.16% to 35,468.65 while the NASDAQ rose 0.60% to 14,142.63. The S&P 500, also rose, gaining, 0.27% to 4,566.98.
